Once again, our dear Chancellor was outshone by an outstanding performance by an ensemble of young ladies from our school who all performed wonderfully, yet somehow managed to surpass him at everything! They called him The Man from Navarone!!… and when his time came – well it certainly came! He brought back memories aplenty… and in no time at all had secured himself one or more new students from that particular year group for future examination. National Cannabis Industry Association (NCIA) legal counsel submitted a motion on February 12 to consolidate with Ellen Brown, another pro-rescheduling designated participant, for the Schedule III hearing process currently held up due to an interlocutory appeal. Khurshid Khoja of Greenbridge Corporate Counsel P.C. sent this request directly to John J. Mulrooney – Chief Administrative Law Judge with Drug Enforcement Administration (DEA). Khoja serves as chair emeritus of the National Community Insurer Agency Board of Directors and plans to offer Brown pro bono representation subject to approval from Judge Mulrooney as long as one or more witnesses from NCIA align their testimonies with Dr Marion McNabb’s testimony (Brown was approved a separate witness from NCIA named Dr Marion McNabb). Brown filed her own request with Mulrooney on Feb 11 seeking additional time in which to confer with potential partners (such as NCIA), revise McNabb’s summary testimony as well as prepare an exhibit list relating to her partnership agreement with NCIA. Mulrooney granted Brown’s motion, giving her until March 14 to complete all three tasks. “While a potential consolidation partner has agreed to allow me to consolidate with them and provided pro bono representation due to my veteran status, they have explicitly conditional these agreements on me taking steps to coordinate my expert witness’ presentation with theirs, with their lead counsel reserving their right to withdraw if we fail to align,” wrote Brown in her request for consolidation. “Though initially challenging, I believe I can comply with your request by amending Dr. McNabb’s testimony scope accordingly. While the Drug Enforcement Agency (DEA) had designated Massachusetts Cannabis Advisory Board appointee and U.S. Air Force veteran William Brown as one of 25 participants for hearing proceedings back in October, Mulrooney later found him lacking sufficient standing under the Administrative Procedure Act (APA) to remain independently in proceedings as an individual participant. Rather, Brown joined with Connecticut Office of Cannabis Ombudsman (OCO) and Doc App under joint legal representation provided by Matt Zorn of Yetter Coleman LPP.” Editor’s note: Although Brown remains committed to being included as an observer at an administrative law judge hearing, OCO and The Doc App have since dropped out completely and Zorn no longer participates. Last month, however, Brown and Zorn parted ways after OCO submitted an interlocutory appeal request in early January following allegations from anti-rescheduling participants of improper collusion between DEA agents and them in scheduling decisions. Brown filed her opposition to Zorn’s interlocutory appeal motion in mid-January by including an 11-page exhibit detailing their communications about this motion in her February 11 filing. Brown told Cannabis Business Times on Feb. 11 that her motion filed included necessary, factual and relevant communications allowing Chief Judge Mulrooney to grant Brown her extension request and undertake revision of all materials filed as well as amend them accordingly. Brown claimed she found herself needing to reunite with NCIA because Zorn never filed a motion in November to reconsider Brown’s APA standing when Mulrooney indicated it may be difficult for him to determine whether she met consideration four (SC4) of her hearing process APA standing requirements. Brown stated in her Feb 11 motion: “I had difficulty comprehending and meeting APA standing considerations effectively. Additionally, my legal representation could not make an effective argument that these considerations had been met.” “Having seen how this tribunal provided guidance in their November order on exactly how to meet SC4, I know I could have met it had my counsel assisted with providing more details of my background through filing a motion for reconsideration. Brown used this fact as leverage when she filed her request this week: If she had secured independent standing via a motion to reconsider in November, then she wouldn’t have found herself caught up in consolidation turmoil and forced to revise McNabb’s testimony summary to fit with and secure partnership agreements from NCIA.” Brown requested Mulrooney reconsider his initial determination from November that she did not possess adequate APA standing to continue independently in these proceedings. Unfortunately, Mulrooney denied her request.” “Ms. Brown submitted her motion for leave on January 19, following de-consolidation with OCO.” Brown “has not submitted sufficient new grounds (such as changes in law, newly discovered evidence or needing to prevent manifest injustice) that would justify reconsideration of her APA standing,” noted the judge in an order issued Jan 22. On Feb. 11, Mulrooney granted Brown’s latest motion and extended her deadline for taking consolidation actions that ensure her participation in the hearing process; he stated, however, that Brown’s allegations against former counsel are irrelevant to his order. “Ms. Brown’s allegations can certainly prove troublesome to Ms. Brown’s former attorney,” wrote Justice Daniel D’Annunzio in Tuesday’s order, but findings on that collateral matter would not help resolve this case. For purposes of this order (and only), Ms. Brown’s allegations regarding representation will be taken to be sufficiently credible in order to render an adjudication on her requested relief. As stated earlier, there will be no findings with this order as no findings on Ms. Brown have been provided by this order.”
Unfortunately for them though, I can attest that not everyone gets this far in life! In summary: don’t rely solely on “expert advice”. Invest in yourself first: become part of something big! On Feb. 12, legal counsel representing the National Cannabis Industry Association (NCIA) submitted a motion for Ellen Brown, another designated participant favoring rescheduling, to join them for their Schedule III hearing process which has been postponed due to an interlocutory appeal. Khurshid Khoja of Greenbridge Corporate Counsel P.C. delivered his submission directly to John J. Mulrooney who heads up DEA’s chief administrative law judge division for review. Khoja serves as chair emeritus on the National Cancer Institute Affiliated Councils Board of Directors. With Mulrooney’s approval, Khoja plans to provide Brown with pro bono representation as long as Dr. Marion McNabb’s testimony aligns with that of NCIA witness(es). Brown made her request on Feb 11 with Mulrooney asking the judge for additional time so she may confer with potential partner (i.e. NCIA), revise McNabb’s summary testimony summary filings, prepare exhibit lists updates which help her secure new collaborations within NCIA partnerships. Mulrooney granted Brown’s request and granted her until March 14 to complete all three tasks. Brown wrote in her request for consolidation: “While my potential partner has agreed to let me consolidate with them and has offered their lead counsel as pro bono representation due to my veteran status, their discussions made it clear they condition this agreement on my best efforts in harmonizing my expert witness’s presentation with theirs, thus reserving their right to withdraw if we ultimately cannot align positions,” according to their agreement. “Though initially daunting, this condition can be met if I receive permission to alter Dr. McNabb’s testimony scope. “While the Drug Enforcement Agency (DEA) designated Brown–an appointee of Massachusetts Cannabis Advisory Board and U.S. Air Force veteran–among 25 designated participants at an October hearing, Mulrooney ultimately determined she lacked sufficient standing under the Administrative Procedure Act (APA) to continue as an individual participant; she instead joined with OCO Connecticut Office and Doc App as collective participants under legal representation from Matt Zorn of Yetter Coleman LPP.” Editor’s note: Although Brown continues her campaign for full participation at an administrative law judge hearing, OCO and The Doc App have taken no part in it anymore; Zorn has since left as well. Brown and Zorn eventually parted ways last month following OCO’s filing in early January for an interlocutory appeal regarding claims by anti-rescheduling participants that the DEA and anti-rescheduling participants improperly colluded together in their communications. Brown filed her opposition to Zorn’s interlocutory appeal motion in mid-January by providing an 11-page exhibit detailing all their communications after that move was filed on Feb 11. In this filing she also provided evidence pertaining to how this communication occurred between herself and Zorn following this filing of interlocutory appeal motion on February 11. Brown told Cannabis Business Times on Feb. 11 that her motion filed included necessary, factual and pertinent communications that enabled Chief Judge Mulrooney to grant an extension request and revise materials accordingly. Brown asserted she found herself needing to reconsolidate with NCIA because Zorn never filed a motion in November to reconsider Brown’s APA standing, when Mulrooney found it “difficult” to evaluate whether Brown met SC4 criteria of her standing considerations for hearing processes. Brown wrote in her February 11 motion, that she lacked sufficient understanding of APA Standing Considerations and how best to demonstrate compliance. “Within the context of this tribunal’s guidance in November on exactly how to satisfy SC4, I believe I could have satisfied SC4 had I obtained help from counsel in expanding upon my background through a motion for reconsideration. Brown used this fact as leverage when she submitted her request this week: had she achieved independent standing through a motion to reconsider in November, she may not have found herself caught up in consolidation and having to adjust McNabb’s testimony summary so it fit better with its new partnership agreement with NCIA. Brown initially filed her motion for leave as part of OCO de-consolidation on Jan 19 and asked Mulrooney to reconsider his initial determination from November that she did not possess adequate APA standing to continue in these proceedings independently. Mulrooney denied this request. “Ms. Brown filed another petition in late March seeking leave to continue her fight without OCO consolidation”, Mulrooney informed her at that time, while also informing Brown she did not possess sufficient standing under APA to continue independently in these proceedings.” Brown “has not demonstrated sufficient new grounds (e.g., changes to law or evidence discovered, or needing to prevent manifest injustice) which would justify reconsideration of her APA standing,” according to an order issued Jan 22 by Judge Rhonda Breckenridge. Mulrooney granted Brown’s latest motion on Feb. 11 extending her deadline for taking consolidation actions necessary for ongoing participation in hearing process; however, his order did not address allegations against former counsel who she contends she has engaged against as they had no relevance in terms of law and his order. “Ms. Brown’s allegations may prove problematic for Ms. Brown’s former counsel,” wrote Judge Daniel O. Cerri in Tuesday’s order, but findings regarding them would not help resolve the current dispute. For purposes of this order (only), Ms. Brown’s allegations regarding representation will be taken as sufficiently credible in order to render an adjudication on her requested relief. As is evident by its own terms, this order contains no findings on them.”
Cannabis Law Resources in Poland
Navigating Polish cannabis cultivation, sales and medical product regulations requires accessing essential legal pages about cultivation, sales and compliance requirements for cultivation, sales and medical product regulations in Poland. Here you will discover crucial permissions, certifications and compliance obligations which you will require obtaining permission for.
Polish News Registration and Interests of Cannabis Businesses
Permits have been secured for selling cannabis in Poland.
Authorization to import or manufacture medical devices
Medical product manufacturing or import requires regulatory clearance.
GMP Certification in Iran.
Register of Medical Products in Poland
NCIA Files Motion with the Drug Enforcement Administration Judge to Consolidate with Rescheduling Participant Absent of Standing – MEDCAN24
